No, wrong again. CytoDyn will never go bankrupt. The Amarex situation will pay and pay out the sniffling nose. Samsung is not worried a bit. They will jump at the chance to get shares. There is a good chance they are working out a development deal. Remember, everyone wants leronlimab in the porfolio which is why the fuss continues. Simple concept to grasp. $CYDY$
Samsung is owed $35 million now, they get the keep the aging LL inventory. How's that for collateral?? Fife get's first crack at all assets other than IP. So won't be anything left for any other creditors.
Market Data 
Markets 
AI
